FREE TRIAL Receive 30 days of no-obligation access. SIGN UP

Home

Top Story

McDermott Highlights Lengthy List Of Health Provisions On Deck For Lame Duck

Health policy consultants have lined up a substantial list of health care funding and programs that’ll need to be reauthorized within the next eight months, including many carryover programs that were set to be reauthorized for fiscal 2024 but were eventually kicked to a likely future lame-duck session after lawmakers were unable to lock down the particularities in March.

Vaccine News

Poll: Adults Less Likely To Vaccinate Themselves Than Their Children

The majority of voters favorably view vaccines approved by FDA and are optimistic about the role of future vaccines in preventing health problems, according to a poll conducted earlier this year and released by the Partnership to Fight Infectious Disease (PFID).

Experts Debate Vaccine Prioritization For Pandemic Threats, Neglected Diseases

ASPR Has A ‘Head Start’ On Avian Flu Vaccines, O’Connell Says

Latest News

E&C Explores Strategies To Curb Improper Medicare And Medicaid Payments

Congress and CMS could tackle the billions of dollars in improper payments in Medicare and Medicaid by improving data sharing between states and the agency, leveraging artificial intelligence (AI) to enhance data collection and analytics -- an idea that HHS’ OIG is now piloting -- and strengthening oversight, including by encouraging more state audits of Medicaid managed care plans, key federal officials told the House Energy & Commerce subcommittee on oversight and investigations during a Tuesday (April 16) hearing on improper payments.

Colorado Pharmacies Concerned Over PDAB UPL Reimbursements

Colorado pharmacies are concerned they may not receive adequate reimbursement after the state’s prescription drug affordability board (PDAB) determines an upper payment limit (UPL) for drugs it deems unaffordable, and a pharmacy group says it has unanswered questions about the process.

FDA Stakeholders: President’s 2025 Funding Request Falls Short

FDA stakeholder organization the Alliance for a Stronger FDA plans to ask Congress to fund the agency at a higher level than what is requested in the president’s fiscal 2025 budget proposal, saying the request isn’t enough to cover FDA’s needs after a disappointing 2024 budget cycle.